This page is the entry point for evaluating Mohammad Rahimi’s MZN case. It does not ask a reviewer to read the whole portfolio first. It defines the proof pathway: method, architecture, pressure test, then evidence room.
Core rule: do not begin with 50 files, a valuation number, a Crunchbase signal, or the one-person-unicorn question. Begin with the evaluation order, then test architectural coherence, then pressure-test objections, then open the evidence room.
The case should be proven through a sequence, not through a single dramatic claim. Each layer answers a different question.
Define the evaluation order, phase boundaries, and proportional reading method before judging any asset or weakness.
/startShow how Phase 1 product signals, Phase 2 AI-native architecture, and Phase 3 Zoyan convergence connect.
/evidence-graphAnswer the hardest questions around theory-only risk, phase mixing, solo provenance, Zoyan, valuation, and evidence.
/hardquestionOnly after the trio, open product, IP, BioCode, HUAI, technical, Crunchbase, OPU, and Phase 3 material selectively.
/evidence-roomThe trio turns a large portfolio into a reviewable system: method, architecture, pressure test.
This page. It explains how to read the case, how to avoid misreading scale, and why the one-person question comes after asset scale and reconstruction cost.
Open /startShows why MZN is not a scattered pile of projects or theory-only writing. It maps executed Phase 1 signals and Phase 2 architecture toward Zoyan.
Open /evidence-graphAnswers the strongest objections conservatively: Phase 1 vs Phase 2, solo formation, Zoyan readiness, IP status, value, and what would defeat the claim.
Open /hardquestionA fair review should not jump directly to “is this a one-person unicorn?” It should first establish what is being evaluated and what scale of evidence is required.
What is the size, breadth, and depth of the asset architecture?
What kind of panel, expertise, evidence access, and time would proper diligence require?
Is this a familiar startup pattern or a new AI-native formation category?
Could the eligible architecture plausibly carry major value after independent diligence?
What would it cost to recreate the same portfolio, architecture, evidence, and timing?
Only then ask whether eligible Phase 2 formation can be proven as materially one-person.
The proof path depends on not mixing Phase 1, Phase 2, and Phase 3.
The evidence room is not the first read. It is the second-stage verification layer.
Mazzaneh, modules, product history, market evidence, income model, users, sellers, and signal logic.
Open roomHuman-grounded AI, capability mapping, LLM anatomy, BioCode AI, biology, and architecture candidates.
Open roomPhase 2 one-person route, role compression, Linas-style skills, provenance, and reconstruction logic.
Open roomRebuild, validation, legal review, AI lab dialogue, pilots, partnership route, and execution plan.
Open roomThe next page is the Evidence Graph: it answers whether MZN is a connected architecture or a pile of unrelated projects.